Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Brand Names
- Penbraya, Trumenba
- Generic Name
- Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen
- DrugBank Accession Number
- DB10284
- Background
Neisseria meningitidis serogroup B recombinant lp2086 a05 protein variant antigen is a sterile vaccine for intramuscular injection indicated for the active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. It is contained in the suspension of Trumenba, which is a vaccine is composed of two recombinant lipidated factor H binding protein (fHBP) variants from N. meningitidis serogroup B, one from fHBP subfamily A and one from subfamily B (A05 and B01, respectively).
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Vaccines
Conjugate - Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Prevention of Infection caused by neisseria meningitidis serogroup b •••••••••••• •••••••••• •••••••••• Used in combination to prevent Infection caused by neisseria meningitidis serogroup b Combination Product in combination with: Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen (DB10285) •••••••••••• •••••••••• •••••••••• - Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Penbraya Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen (0.06 mg/0.5mL) + Neisseria meningitidis group A capsular polysaccharide tetanus toxoid conjugate antigen (5 ug/0.5mL) + Neisseria meningitidis group C capsular polysaccharide tetanus toxoid conjugate antigen (5 ug/0.5mL) + Neisseria meningitidis group W-135 capsular polysaccharide tetanus toxoid conjugate antigen (5 ug/0.5mL) + Neisseria meningitidis group Y capsular polysaccharide tetanus toxoid conjugate antigen (5 ug/0.5mL) + Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen (0.06 mg/0.5mL) Injection, powder, lyophilized, for suspension; Kit; Suspension Intramuscular Pfizer Laboratories Div Pfizer Inc 2023-11-27 Not applicable US TRUMENBA Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen (60 mcg/0.5mL) + Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen (60 mcg/0.5mL) Injection, suspension Intramuscular Pfizer Europe Ma Eeig 2018-02-01 Not applicable Italy Trumenba Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen (60 mcg/0.5ml) + Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen (60 mcg/0.5ml) Injection, suspension Intramuscular Pfizer Europe Ma Eeig 2021-02-12 Not applicable EU Trumenba Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen (60 mcg/0.5ml) + Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen (60 mcg/0.5ml) Injection, suspension Intramuscular Pfizer Europe Ma Eeig 2021-02-12 Not applicable EU TRUMENBA Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen (60 mcg/0.5mL) + Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen (60 mcg/0.5mL) Injection, suspension Intramuscular Pfizer Europe Ma Eeig 2018-02-01 Not applicable Italy
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 583WCD0IZI
- CAS number
- Not Available
References
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Other Meningococcal Infections 1 4 Completed Prevention Meningococcal Vaccines 1 3 Completed Prevention Meningococcal Immunisation (Healthy Volunteers) 1 3 Completed Prevention Meningococcal Vaccines 1 3 Recruiting Prevention Splenectomy 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, powder, lyophilized, for suspension; kit; suspension Intramuscular Injection, suspension Intramuscular Suspension Intramuscular - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:52